Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02853331
Brief Title: Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

First Submitted : July 29, 2016
First Submitted that Met QC Criteria : July 29, 2016
First Posted : August 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 18, 2019
Last Update Posted : March 20, 2019